TABLE 3.
Top 10 pharmaceutical companies by the number of reports in the two pharmacovigilance databases.
| Company name | Reported events in the FAERS (N = 4,752) | % | Company name | Reported events in the EV (N = 1,049) | % |
|---|---|---|---|---|---|
| Pfizer | 904 | 19.02% | Sanofi-Aventis Groupe | 160 | 15.25% |
| Eli Lilly and Co. | 409 | 8.61% | Roche Products Limited | 145 | 13.82% |
| FDA-CTU | 263 | 5.53% | EEA Regulator | 122 | 11.63% |
| Janssen | 244 | 5.13% | Pfizer S.R.L. | 89 | 8.48% |
| Johnson and Johnson | 197 | 4.15% | Bristol-Myers Squibb Belgium | 85 | 8.10% |
| Roche | 196 | 4.12% | Eli Lilly and Company Limited | 74 | 7.05% |
| Teva | 138 | 2.90% | Bayer AG | 73 | 6.96% |
| AbbVie | 132 | 2.78% | Janssen-Cilag Limited | 52 | 4.96% |
| Purdue | 129 | 2.71% | Gilead Sciences International Limited | 46 | 4.39% |
| Bristol-Myers Squibb | 103 | 2.17% | Merck and Co., Inc. | 42 | 4.00% |